🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
27.32
+0.42 (1.54%)
At close: Nov 19, 2026, 4:00 PM EST
27.03
-0.29 (-1.04%)
Pre-market: Nov 20, 2026, 4:03 AM EST

Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of $1.45 billion. The enterprise value is $1.44 billion.

Market Cap1.45B
Enterprise Value 1.44B

Important Dates

The last earnings date was Thursday, September 24, 2026, after market close.

Earnings Date Sep 24, 2026
Ex-Dividend Date n/a

Share Statistics

Nanobiotix has 50.80 million shares outstanding. The number of shares has increased by 2.40% in one year.

Current Share Class n/a
Shares Outstanding 50.80M
Shares Change (YoY) +2.40%
Shares Change (QoQ) +1.37%
Owned by Insiders (%) 3.97%
Owned by Institutions (%) 18.31%
Float 35.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 110.05
Forward PS 18.56
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 109.69
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.44

Current Ratio 1.44
Quick Ratio 1.40
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.43

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -60.94%
Return on Invested Capital (ROIC) -66.69%
Return on Capital Employed (ROCE) -69.86%
Weighted Average Cost of Capital (WACC) 7.84%
Revenue Per Employee $134,135
Profits Per Employee -$616,302
Employee Count98
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

In the past 12 months, Nanobiotix has paid $14,852 in taxes.

Income Tax 14,852
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +25.30% in the last 52 weeks. The beta is 0.54, so Nanobiotix's price volatility has been lower than the market average.

Beta (5Y) 0.54
52-Week Price Change +25.30%
50-Day Moving Average 29.52
200-Day Moving Average 34.44
Relative Strength Index (RSI) 42.39
Average Volume (20 Days) 145,955

Short Selling Information

The latest short interest is 170,082, so 0.45% of the outstanding shares have been sold short.

Short Interest 170,082
Short Previous Month 196,508
Short % of Shares Out 0.45%
Short % of Float n/a
Short Ratio (days to cover) 1.14

Income Statement

In the last 12 months, Nanobiotix had revenue of $13.15 million and -$60.40 million in losses. Loss per share was -$1.20.

Revenue13.15M
Gross Profit 13.15M
Operating Income -33.84M
Pretax Income -60.38M
Net Income -60.40M
EBITDA -34.03M
EBIT -33.84M
Loss Per Share -$1.20
Full Income Statement

Balance Sheet

The company has $126.69 million in cash and $121.80 million in debt, with a net cash position of $4.89 million or $0.10 per share.

Cash & Cash Equivalents 126.69M
Total Debt 121.80M
Net Cash 4.89M
Net Cash Per Share $0.10
Equity (Book Value) -38.14M
Book Value Per Share -0.75
Working Capital 42.90M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$37.53 million and capital expenditures -$1.11 million, giving a free cash flow of -$38.64 million.

Operating Cash Flow -37.53M
Capital Expenditures -1.11M
Depreciation & Amortization -182,238
Net Borrowing 42.31M
Free Cash Flow -38.64M
FCF Per Share -$0.76
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -257.43%
Pretax Margin -459.35%
Profit Margin n/a
EBITDA Margin -258.87%
EBIT Margin -257.43%
FCF Margin n/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -2.40%
Shareholder Yield -2.40%
Earnings Yield -4.38%
FCF Yield -2.67%

Analyst Forecast

The average price target for Nanobiotix is $53.35, which is 95.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target $53.35
Price Target Difference 95.31%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) 49.46%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Nanobiotix has an Altman Z-Score of 2.89 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.89
Piotroski F-Score 2